How Analysts Feel About IntelliPharmaCeutics International Inc. After Today’s Huge Decline?


The stock of IntelliPharmaCeutics International Inc. (TSE:I) is a huge mover today! The stock decreased 7.87% or $0.2 on September 13, hitting $2.34. About 23,215 shares traded hands or 101.10% up from the average. IntelliPharmaCeutics International Inc. (TSE:I) has declined 18.06% since February 5, 2016 and is downtrending. It has underperformed by 34.55% the S&P500.
The move comes after 9 months negative chart setup for the $60.00 million company. It was reported on Sep, 14 by We have $2.04 PT which if reached, will make TSE:I worth $7.80 million less.

Intellipharmaceutics International Inc. is a pharmaceutical firm specializing in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. The company has a market cap of $60.00 million. The Company’s Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. It currently has negative earnings. It has developed several drug delivery systems and a pipeline of products and product candidates in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply